DPP4-MVP

N/A

Report date: 2025/05/07 16:33:41

Base Information

Drug NameDPP4-MVP
Drug Alias NameDPP4-MVP
ClassificationBiologics
Mechanisms of ActionDipeptidyl peptidase IV modulators
TargetsDipeptidyl peptidase IV
Therapy Area/IndicationsMiddle East Respiratory Syndrome Coronavirus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAchelois BioPharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesAchelois BioPharma Inc
Inactive CompaniesN/A
Active IndicationsMiddle East Respiratory Syndrome Coronavirus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A